These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6893689)

  • 1. [Nuclear medicine aspects of Basedow's disease and other forms of hyperthyroidism].
    Horster FA
    Chirurg; 1980 Oct; 51(10):615-8. PubMed ID: 6893689
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis, clinical aspects and internal therapy of Basedow's disease and other forms of hyperthyroidism].
    Studer H
    Chirurg; 1980 Oct; 51(10):613-4. PubMed ID: 6893688
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basedow's disease and thyroid stimulating hormone producing pituitary adenoma in a patient].
    Frandsen NJ; Transbøl I
    Ugeskr Laeger; 1991 Mar; 153(12):854-5. PubMed ID: 2014575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism.
    Gharib H; Carpenter PC; Scheithauer BW; Service FJ
    Mayo Clin Proc; 1982 Sep; 57(9):556-63. PubMed ID: 7109684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vivo determination of thyroid iodine content in functional autonomy].
    Leisner B
    Acta Med Austriaca; 1990; 17 Suppl 1():33-5. PubMed ID: 2117838
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperthyroidism due to a thyrotropin-secreting pituitary microadenoma.
    Jackson JA; Smigiel M; Greene JF
    Henry Ford Hosp Med J; 1987; 35(4):198-200. PubMed ID: 3448053
    [No Abstract]   [Full Text] [Related]  

  • 7. [A differential diagnosis: toxic adenoma or partial thyroid agenesis with Basedow's disease of the remaining lobe].
    Mirouze J; Jaffiol C; Seignalet J; Pastorello R; Baldet L
    Rev Fr Endocrinol Clin; 1967; 8(2):161-4. PubMed ID: 6072294
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin.
    Terzolo M; Orlandi F; Bassetti M; Medri G; Paccotti D; Cortelazzi D; Angeli A; Beck-Peccoz P
    J Clin Endocrinol Metab; 1991 Feb; 72(2):415-21. PubMed ID: 1704010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary hyperthyroidism: report of three cases.
    Ehmann C; Krauss DS; Kahn CB
    R I Med J (1976); 1984 Oct; 67(10):443-7. PubMed ID: 6593784
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyrotropin-secreting pituitary adenoma.
    Chang TJ; Chang TC; Lin SM; Huang SF; Pai YH
    J Formos Med Assoc; 1998 Dec; 97(12):860-5. PubMed ID: 9884490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthyroidism, inappropriate plasma TSH and pituitary adenoma in three patients, two receiving long-term phenothiazine therapy.
    Dunne FP; Feely MP; Ferriss JB; Keohane C; Murphy D; Perry I
    Q J Med; 1990 Apr; 75(276):345-54. PubMed ID: 2117296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to the study of hot thyroid nodules].
    Bru A; Lucot H; Combes PF; Regis H
    J Radiol Electrol Med Nucl; 1966 Nov; 47(11):694-6. PubMed ID: 6013395
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperthyroidism with an FSH-and TSH-secreting pituitary adenoma.
    Bermingham J; Haenel LC
    J Am Osteopath Assoc; 1989 Dec; 89(12):1560-6. PubMed ID: 2482837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed TSH- and HGH-secreting pituitary adenoma.
    Coculescu M; Pop A; Constantinovici A; Oprescu M; Temeli E; Marinescu I
    Endocrinologie; 1982; 20(3):209-16. PubMed ID: 7146814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and nuclear medical diagnostic characteristics of toxic thyroid adenoma].
    Filatov AA
    Radiol Diagn (Berl); 1979; 20(5):776-82. PubMed ID: 531211
    [No Abstract]   [Full Text] [Related]  

  • 17. Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.
    Gruszka A; Zielinski GM; Kunert-Radek J
    J Clin Neurosci; 2014 Feb; 21(2):340-2. PubMed ID: 23958483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSH secreting pituitary adenoma in children: a case report.
    Suntornlohanakul S; Vasiknanont P; Mo-Suwan L; Phuenpathom N; Chongchitnant N
    J Med Assoc Thai; 1990 Mar; 73(3):175-8. PubMed ID: 2380650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the problems of pathogenesis of Basedow's disease and thyrotoxicosis as well as endocrine ophthalmopathy].
    Bansi HW
    Dtsch Med Wochenschr; 1965 Nov; 90(47):2089-95. PubMed ID: 5897892
    [No Abstract]   [Full Text] [Related]  

  • 20. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas.
    Losa M; Giovanelli M; Persani L; Mortini P; Faglia G; Beck-Peccoz P
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3084-90. PubMed ID: 8768879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.